Eastham Karin
- SEC CIK
- 0001231845
In the past year, 3 open-market sale filings worth $1.49M and no purchases.
Current role at each company
- VCYT Veracyte, Inc.Directoras of Jun 22, 2026
- PSNL Personalis, Inc.Directoras of Jun 11, 2026
- GERN Geron CorpDirectoras of Jan 17, 2023
- NKTR Nektar TherapeuticsDirectoras of Sep 20, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $1.49M
- 3 filings
- Net
- −$1.49M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Eastham Karin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VCYT Veracyte, Inc.
Director15 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 (view filing) | Jun 18 | 4 days | Eastham KarinDirector | SSale | −3.73K | $52.89 | −$197.2K | −19.8%15.1K after | 2 lots10b5-1 |
| Dec 8, 2025 (view filing) | Dec 5 | 3 days | Eastham KarinDirector | SSale | −20.0K | $45.45 | −$909.0K | −59.6%13.6K after | 3 lots10b5-1 |
| Nov 7, 2025 (view filing) | Nov 5 | 2 days | Eastham KarinDirector | SSale | −9.67K | $40.02 | −$387.2K | −41.6%13.6K after | 10b5-1 |
| Jun 17, 2025 (view filing) | Jun 13 | 4 days | Eastham KarinDirector | SSale | −4.59K | $26.66 | −$122.4K | −24.8%13.9K after | 10b5-1 |
| Jan 6, 2025 (view filing) | Jan 2 | 4 days | Eastham KarinDirector | SSale | −10.0K | $40.30 | −$403.0K | −35.1%18.5K after | 2 lots10b5-1 |
| Nov 21, 2024 (view filing) | Nov 19 | 2 days | Eastham KarinDirector | SSale | −14.7K | $38.34 | −$564.8K | −44.3%18.5K after | 3 lots10b5-1 |
| Jul 18, 2024 (view filing) | Jul 16 | 2 days | Eastham KarinDirector | SSale | −7.50K | $25.00 | −$187.5K | −18.4%33.2K after | 10b5-1 |
| Jun 13, 2024 (view filing) | Jun 11 | 2 days | Eastham KarinDirector | SSale | −3.87K | $20.59 | −$79.7K | −11.7%29.3K after | 10b5-1 |
| Jun 11, 2024 (view filing) | Jun 7 | 4 days | Eastham KarinDirector | SSale | −2.50K | $20.97 | −$52.4K | −7.0%33.1K after | 10b5-1 |
| Apr 2, 2024 (view filing) | Apr 1 | 1 day | Eastham KarinDirector | SSale | −10.0K | $21.65 | −$216.5K | −23.2%33.1K after |
NKTR Nektar Therapeutics
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2022 (view filing) | Sep 13 | 1 day | Eastham KarinDirector | SSale | −21.3K | $3.61 | −$76.8K | −62.0%13.0K after |